Literature DB >> 8138937

Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.

G Eisenhofer1, J P Finberg.   

Abstract

Normetanephrine (NMN) and metanephrine (MN), are the O-methylated metabolites of norepinephrine (NE) and epinephrine (E), whereas dihydroxyphenylglycol (DHPG) is the deaminated metabolite of both NE and E. This study compared production of NMN, MN and DHPG during tracer and high-dose infusions of Ne and E in rats, with and without inhibition of catechol-O-methyltransferase (COMT) or the A and B forms of monoamine oxidase (MAO). Animals also received infusions of NMN and MN to compare plasma clearances and spillovers of NMN and MN with and without MAO inhibition. Inhibition of COMT increased plasma DHPG and decreased plasma NMN and MN, whereas inhibition of MAO decreased plasma DHPG and increased plasma NMN and MN. The increase in NMN and MN after MAO inhibition reflected blocked deamination of NMN and MN by MAO-A, but not MAO-B. The A form of MAO was also largely responsible for deamination of NE. Infused E was deaminated to DHPG less efficiently than NE. High doses of infused E were O-methylated more efficiently than NE, whereas tracer doses were O-methylated similarly. After MAO inhibition NE was O-methylated more efficiently than E. Increased plasma NMN after MAO inhibition reflected the combined effects of a decrease in the plasma clearance of NMN and an increase in the spillover of NMN into plasma, whereas the smaller increase in plasma MN was due solely to a decrease in the plasma clearance of MN. Thus, E and MN are not deaminated at extraneuronal sites of O-methylation, whereas NE is both O-methylated and deaminated with proportionally more deaminated than O-methylated as the concentration of NE increases. The above results support the preference of NE over E for neuronal pathways of metabolism, but indicate considerably more complex differences in the metabolism of NE and E by extraneuronal O-methylation and deamination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138937

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

Review 2.  Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.

Authors:  Jiaojiao Li; Chunxiao Sun; Wenwen Cai; Jing Li; Barry P Rosen; Jian Chen
Journal:  Mutat Res Rev Mutat Res       Date:  2021-10-07       Impact factor: 7.015

3.  Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery.

Authors:  Anja Haase-Fielitz; Michael Haase; Rinaldo Bellomo; Gavin Lambert; George Matalanis; David Story; Laurie Doolan; Brian Buxton; Geoff Gutteridge; Friedrich C Luft; Wolf-Hagen Schunck; Duska Dragun
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

4.  20 ans après: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition.

Authors:  Amélie Piton; Hélène Poquet; Claire Redin; Alice Masurel; Julia Lauer; Jean Muller; Julien Thevenon; Yvan Herenger; Sophie Chancenotte; Marlène Bonnet; Jean-Michel Pinoit; Frédéric Huet; Christel Thauvin-Robinet; Anne-Sophie Jaeger; Stéphanie Le Gras; Bernard Jost; Bénédicte Gérard; Katell Peoc'h; Jean-Marie Launay; Laurence Faivre; Jean-Louis Mandel
Journal:  Eur J Hum Genet       Date:  2013-10-30       Impact factor: 4.246

5.  Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Authors:  J W Lenders; G Eisenhofer; N G Abeling; W Berger; D L Murphy; C H Konings; L M Wagemakers; I J Kopin; F Karoum; A H van Gennip; H G Brunner
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

6.  Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.

Authors:  David Braun; Jose L M Madrigal; Douglas L Feinstein
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

7.  Neural and sympathetic activity associated with exploration in decision-making: further evidence for involvement of insula.

Authors:  Hideki Ohira; Naho Ichikawa; Kenta Kimura; Seisuke Fukuyama; Jun Shinoda; Jitsuhiro Yamada
Journal:  Front Behav Neurosci       Date:  2014-11-10       Impact factor: 3.558

8.  Perinatal MAO Inhibition Produces Long-Lasting Impairment of Serotonin Function in Offspring.

Authors:  Mark W Burke; Myriam Fillion; Jose Mejia; Frank R Ervin; Roberta M Palmour
Journal:  Brain Sci       Date:  2018-06-11

9.  Analysis of the source of aggressiveness in gamecocks.

Authors:  Tomoyoshi Komiyama; Masanobu Yoshikawa; Keiko Yokoyama; Hiroyuki Kobayashi
Journal:  Sci Rep       Date:  2020-04-24       Impact factor: 4.379

10.  Effects of humeral intraosseous epinephrine in a pediatric hypovolemic cardiac arrest porcine model.

Authors:  Michael James Neill; James M Burgert; Dawn Blouin; Benjamin Tigges; Kari Rodden; Rachel Roberts; Phillip Anderson; Travis Hallquist; John Navarro; Joseph O'Sullivan; Don Johnson
Journal:  Trauma Surg Acute Care Open       Date:  2020-02-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.